Latest Content

Premiums for coverage on the ACA marketplaces are set to jump by an average of 26% next year, even before the expiration of subsidies is factored in.

The antiretroviral (ART) regimen Biktarvy showed higher 1-year ART persistence and lower switch rates among people with HIV.

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies to enhance patient care and outcomes.

Cancer care evolves with innovative therapies and financial challenges, emphasizing the need for equitable access and sustainable models in treatment delivery.

Real-world evidence helps pharmaceutical companies and payers communicate more effectively.

Oncology experts discuss the rapid advancements in cancer diagnostics and treatments, emphasizing the need for equitable access and infrastructure improvements.

Metabolic intermediates were identified as active participants in fibrosis progression and potential targets for next-generation therapies.

Experts discuss strategies for equitable access to genomic testing and cutting-edge therapies for uninsured non-small cell lung cancer patients.

Real-world data suggest metabolic dysfunction-associated steatotic liver disease is also associated with higher all-cause mortality.